LMNX

Luminex Corporation

Price

$7.75

return (12m)

0.00%

p/e

27.54

p/bv

1.33

DIVIDEND YIELD

0.00%

LMNX price

Luminex

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LMNX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-60.56%

3 months

-43.35%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

-62.73%

Fundamentals LMNX

Valuation

P/E

27.54

Sector -4.01

Industry -4.01

P/BV

1.33

Sector 2.04

Industry 2.04

P/Revenue (PSR)

1.49

Sector -4.27

Industry -4.27

EV/EBITDA

30,907,274.46

Sector -238.24

Industry -238.24

EV/EBIT

49,278,239.72

Sector -670.52

Industry -670.52

P/EBITDA

7.75

Sector -4.23

Industry -4.23

P/EBIT

12.26

Sector -4.26

Industry -4.26

P/Total Assets

0.79

Sector 1.45

Industry 1.45

P/Net Current Assets

4,309,926.40

Sector -13.26

Industry -13.26

P/Working Capital

1,532,140.58

Sector -11.36

Industry -11.36

EPS

0.51

Sector -2.20

Industry -2.20

BVPS

10.61

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

60.31%

Sector 36.28%

Industry 36.28%

EBITDA Margin

19.00%

Sector -16,823.42%

Industry -16,823.42%

EBIT Margin

11.92%

Sector -4,238,733.37%

Industry -4,238,733.37%

Operating Margin

12.40%

Sector -38.78%

Industry -38.78%

Net Profit Margins

5.39%

Sector -39.92%

Industry -39.92%

Asset Turnover

0.14

Sector 0.03

Industry 0.03

Profitability

ROE

4.84%

Sector -65.94%

Industry -65.94%

ROA

2.88%

Sector -66.10%

Industry -66.10%

ROIC

8.87%

Sector -2,918.74%

Industry -2,918.74%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

8.37

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-0.86

Sector -13,526,126.10

Industry -13,526,126.10

Net Debt / EBIT

-1.37

Sector -3.64

Industry -3.64

Net Debt / Equity

-0.04

Sector -1.10

Industry -1.10

Gross Debt / Equity

0.52

Sector -0.10

Industry -0.10

Equity/Assets

0.60

Sector 0.42

Industry 0.42

Liabilities/Assets

0.40

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

31.65%

Sector -

Industry -

5Y Earnings CAGR

21.05%

Sector -

Industry -

FAIR VALUE OF Luminex ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$7.75

Fair Value

$11.03

Upside Return potential.

42.37%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LMNX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LMNX	27.54	1.33	4.84%	0.00%	$649.98 M	5.39%
JNJ	29.55	7.32	24.76%	2.03%	$621.61 B	21.48%
PFE	18.39	1.52	8.29%	7.11%	$137.74 B	11.83%
NVO	11.48	6.93	60.40%	3.79%	$217.68 B	37.15%
MRK	36.33	7.07	19.45%	2.56%	$324.61 B	13.59%
GILD	17.54	6.90	39.33%	2.47%	$161.64 B	30.99%
ZTS	11.99	9.80	81.75%	2.74%	$31.69 B	27.79%
HALO	27.62	43.86	158.82%	0.00%	$9.63 B	23.13%
AMGN	26.05	22.11	84.87%	2.60%	$203.18 B	20.96%
MCK	21.59	-123.30	-570.98%	0.39%	$102.83 B	1.18%
VRTX	28.04	6.28	22.41%	0.00%	$121.66 B	35.51%
CAH	34.58	-20.13	-58.20%	0.89%	$53.78 B	0.62%
HRMY	14.10	2.26	16.00%	0.00%	$2.05 B	16.20%
MEDP	34.42	38.99	113.29%	0.00%	$16.92 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LMNX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/15/2021	07/08/2021	0.10000000
Dividends	03/23/2021	04/15/2021	0.10000000
Dividends	12/21/2020	01/14/2021	0.10000000
Dividends	09/22/2020	10/15/2020	0.09000000
Dividends	06/16/2020	07/09/2020	0.09000000
Dividends	03/17/2020	04/09/2020	0.09000000
Dividends	12/17/2019	01/15/2020	0.09000000
Dividends	09/24/2019	10/17/2019	0.09000000
Dividends	06/18/2019	07/11/2019	0.06000000
Dividends	03/19/2019	04/11/2019	0.06000000
Dividends	12/18/2018	01/10/2019	0.06000000
Dividends	09/19/2018	10/12/2018	0.06000000
Dividends	06/20/2018	07/13/2018	0.06000000
Dividends	03/21/2018	04/13/2018	0.06000000
Dividends	12/20/2017	01/12/2018	0.06000000
Dividends	09/20/2017	10/13/2017	0.06000000
Dividends	06/21/2017	07/14/2017	0.06000000
Dividends	03/22/2017	04/14/2017	0.06000000

ABOUT Luminex

Luminex Corporation

Average Investor10 user rating

4.0 (0 people)

United States

31 years

Founded: 1995

2000

Time since IPO - 26 years

1.325

Employees

Luminex Corporation (United States) is listed on the Nasdaq and has a market capitalization of $649.98 million, with shareholders equity totaling $488.05 .

The company employs approximately 1.325 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Luminex Corporation reported $437.66 in revenue, generating net income of $23.60 .

Key financial metrics include a P/E ratio of 27.54, a price-to-book (P/B) ratio of 1.33, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LMNX.

Market cap

$649.98 million

Net worth

$488.05

Assets

$819.03

Total Shares Outstanding

46.00

000

Average Daily Trading Volume

$33.85 Thousand

$33,847.32

Sector

Health Care

Industry

Biotechnology

LMNX

LMNX revenue and profits

Financial Results LMNX

DRAG THE FRAME TO SEE MORE DATA

LMNX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

JNJ - Johnson & Johnson

$258.25 58,21% (12M)

P/E

29.55

2.03%

ROE

24.76%

P/BV

7.32

MTP - Midatech Pharma

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-10,615.69%

P/BV

0.01

ARGX - argenx

$855.00 26,89% (12M)

P/E

6.07

0.00%

ROE

101.41%

P/BV

6.15

PPD - PPD

$- -0,00% (12M)

P/E

47.29

0.00%

ROE

-84.64%

P/BV

-40.03

ALNY - Alnylam Pharmaceuticals

$203.44 --49,37% (12M)

P/E

ROE

P/BV

GLPG - Galapagos NV

$- -0,00% (12M)

P/E

4.50

0.00%

ROE

10.31%

P/BV

0.46

BGNE - BeiGene

$- -0,00% (12M)

P/E

-22.41

0.00%

ROE

-25.04%

P/BV

5.61